This content is from: Corporate

DEAL: CVS’ proposed $69 billion acquisition of Aetna

The US pharmacy company has agreed a large breakup fee should the deal fall through, suggesting confidence that it will proceed unscathed

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial